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Abstract
Purpose: Interstitial fluid pressure (IFP) is highly elevated in many solid tumors. High IFP has been associated with low
radiocurability and high metastatic frequency in human melanoma xenografts and with poor survival after radiation therapy
in cervical cancer patients. Abnormalities in tumor vascular networks have been identified as an important cause of elevated
tumor IFP. The aim of this study was to investigate the relationship between tumor IFP and the functional and
morphological properties of tumor vascular networks.
Materials and Methods: A-07-GFP and R-18-GFP human melanomas growing in dorsal window chambers in BALB/c nu/nu
mice were used as preclinical tumor models. Functional and morphological parameters of the vascular network were
assessed from first-pass imaging movies and vascular maps recorded after intravenous bolus injection of 155-kDa
tetramethylrhodamine isothiocyanate-labeled dextran. IFP was measured in the center of the tumors using a Millar catheter.
Angiogenic profiles of A-07-GFP and R-18-GFP cells were obtained with a quantitative PCR array.
Results: High IFP was associated with low growth rate and low vascular density in A-07-GFP tumors, and with high growth
rate and high vascular density in R-18-GFP tumors. A-07-GFP tumors showed chaotic and highly disorganized vascular
networks, while R-18-GFP tumors showed more organized vascular networks with supplying arterioles in the tumor center
and draining venules in the tumor periphery. Furthermore, A-07-GFP and R-18-GFP cells differed substantially in angiogenic
profiles. A-07-GFP tumors with high IFP showed high geometric resistance to blood flow due to high vessel tortuosity. R-18-
GFP tumors with high IFP showed high geometric resistance to blood flow due to a large number of narrow tumor
capillaries.
Conclusions: High IFP in A-07-GFP and R-18-GFP human melanoma xenografts was primarily a consequence of high blood
flow resistance caused by tumor-line specific vascular abnormalities.
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Introduction
While the interstitial fluid pressure (IFP) in normal tissues is
actively controlled and remains close to atmospheric levels, IFP in
most human tumors is highly elevated [1]. Measurements of IFP in
a wide range of tumor types have given typical IFP values in the
range of 10 to 40 mmHg [2–4], and IFP values as high as
100 mmHg have been measured in subcutaneous nodules in
melanoma patients [5]. Theoretical and experimental studies have
identified elevated IFP as an important barrier to drug delivery
and, particularly, the delivery of monoclonal antibodies and other
macromolecular drugs that depend on transport by convection
rather than diffusion [6–8]. Furthermore, high IFP in the primary
tumor has been shown to predict poor survival after radiation
therapy in cervical cancer patients independent of tumor
oxygenation and other prognostic factors [9,10]. Preclinical studies
of human melanoma xenografts in our lab have shown an
association between high IFP and low radiocurability through
both hypoxia-dependent and hypoxia-independent mechanisms
[11,12]. Moreover, high IFP was associated with high incidence of
pulmonary and lymph node metastasis in small tumors without
hypoxic regions [13].
The elevated IFP in solid tumors is a consequence of increased
transcapillary fluid flow, increased resistance to interstitial fluid
flow, and impaired lymphatic drainage [1,6]. Increased transcap-
illary fluid flow results from severe structural and functional
abnormalities in the microvasculature of tumors [14–16]. Tumor
vessels show high permeability to fluid and macromolecules as a
result of incomplete endothelial lining, discontinuous or absent
basement membranes, and lack of pericyte coverage [14].
Furthermore, tumor vascular networks are characterized by
tortuous and elongated vessels, arterio-venous shunts, blind ends,
excessive branching, increased intervessel distances, and loss of
vessel hierarchy [15,16]. Consequently, these networks show high
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pressure in the tumor vessels and drives the flow of fluid from the
vascular to the interstitial space [17,18]. Effective transport of this
fluid through the interstitial space is hindered by interstitial
abnormalities, including high cell densities and increased stiffness
of the extracellular matrix [6]. Furthermore, most solid tumors
lack functional lymphatics within the tumor compartment [1,19].
Drainage of excess fluid from the tumor interstitium is thus
impaired. The net result is accumulation of fluid and, hence,
increased fluid pressure in the interstitial space. In experimental
tumors, IFP has been found to be uniformly elevated throughout
the tumor and to drop steeply towards atmospheric levels in the
tumor periphery [13,20].
IFP has been shown to vary widely among individual human
tumors of the same histological type [5], and among xenografted
tumors of the same tumor line [13]. Moreover, it has been shown
experimentally that the increase in tumor IFP occurs early in
tumor development and in close association with tumor angio-
genesis [21]. Physiological angiogenesis is a tightly regulated
process controlled by the balance and interplay of several pro- and
anti-angiogenic factors. Tumors induce angiogenesis by upregulat-
ing pro-angiogenic factors, and by downregulating anti-angiogenic
factors, thereby tipping the balance in favor of the pro-angiogenic
factors [22,23]. The uncontrolled and stochastic nature of the
angiogenic process in tumors leads to the structural and functional
abnormalities characteristic of tumor vascular networks and,
furthermore, it leads to large intertumor heterogeneity in vascular
parameters [16]. The large intertumor heterogeneity in IFP
observed in tumors of the same histological type is therefore
believed to reflect intertumor heterogeneity in vascular perme-
ability and/or blood flow resistance [1]. As most tumors show high
vascular permeability, the microvascular pressure has been
proposed to be the principle driving force for elevated IFP in
tumors [18,24]. Thus, as fluid can move relatively freely between
the vascular and interstitial space, any gradient in fluid pressure
across the vessel wall is quickly neutralized. Consequently, an
increase in microvascular pressure as a result of high blood flow
resistance will be followed by a corresponding increase in IFP.
Lowering of tumor IFP has the potential of improving patient
outcome both by increasing the effect of conventional therapies
and by reducing the risk of distant metastasis. Several strategies to
lower tumor IFP are being investigated [25–30]. As a result of the
close relationship between IFP and tumor angiogenesis, many of
these strategies are directed towards the tumor vasculature. One
such strategy is anti-angiogenic therapy. Treatment with agents
that block the function of pro-angiogenic factors has been
proposed as a strategy to transiently restore the balance between
pro- and anti-angiogenic factors and, thus, normalize the tumor
vasculature [27]. Vascular normalization could potentially reduce
IFP by reducing vascular permeability and/or by reducing the
blood flow resistance. Consequently, a decrease in IFP after anti-
angiogenic therapy has been demonstrated in both experimental
[28,29] and human tumors [30]. The underlying mechanisms are
however not well understood.
Even though the microvascular pressure is believed to be the
principle driving force for elevated IFP in solid tumors, few
experimental studies have investigated in detail the relationship
between vascular morphology, vascular function, and elevated
IFP. Intravital microscopy provides detailed information on both
the functional and structural properties of tumor vascular
networks, and is thus a well-suited method to study vascular
abnormalities causing elevated IFP. In the current study,
xenografted A-07-GFP and R-18-GFP human melanomas were
subjected to intravital microscopy and subsequent IFP measure-
ment. A detailed analysis of vascular morphology and function
showed that high IFP was associated with high blood flow
resistance caused by tumor-line specific vascular abnormalities.
Materials and Methods
Ethics statement
All animal experiments were approved by The Norwegian
Animal Research Authority (approval number: FOTS-2751) and
were performed according to the Interdisciplinary Principles and
Guidelines for the Use of Animals in Research, Marketing, and
Education (New York Academy of Sciences, New York, NY).
Mice
Adult (8–120 weeks of age) female BALB/c nu/nu mice were
used as host animals for dorsal window chamber preparations.
The mice were bred at our institute and maintained under specific
pathogen-free conditions at constant temperature (24–126uC) and
humidity (30–120%). Sterilized food and tap water were given ad
libitum.
Cells and Multicellular Spheroids
A-07 and R-18 human melanoma cells [31] were constitutively
transfected with green fluorescent protein (GFP) by lipofection.
The transfected cells (A-07-GFP and R-18-GFP) were grown as
monolayers in RPMI 1640 (25 mM HEPES and l-glutamine)
supplemented with 13% bovine calf serum, 250 mg/ml penicillin,
50 mg/ml streptomycin, and 700 mg/ml (A-07-GFP) or 2200 mg/
ml (R-18-GFP) genetecin. Multicellular spheroids were produced
and maintained by using a liquid-overlay culture technique [32].
Cell and spheroid cultures were incubated at 37uC in a humidified
atmosphere of 5% CO2 in air and subcultured twice a week.
Anesthesia
Window chamber implantation, intravital microscopy, and IFP
measurements were carried out with anesthetized mice. Fentanyl
citrate (Janssen Pharmaceutica, Beerse, Belgium), fluanisone
(Janssen Pharmaceutica), and midazolam (Hoffmann-La Roche,
Basel, Switzerland) were administered intraperitoneally (i.p.) in
doses of 0.63 mg/kg, 20 mg/kg, and 10 mg/kg, respectively. After
surgery, the mice were given buprenorphine (Temgesic; Schering-
Plough, Brussels, Belgium) i.p. in a dose of 0.12 mg/kg. The body
core temperature of the mice was maintained at 37–128uCb y
using a hot air generator during intravital microscopy and a
heating pad during window chamber implantation and IFP
measurements.
Window Chamber Preparations
Window chambers were implanted into the dorsal skin fold as
described previously [33]. Briefly, the chamber consisted of two
parallel frames that sandwiched an extended double layer of skin.
Before the chamber was implanted, a circular hole with a diameter
of ,6.0 mm was made in one of the skin layers. A plastic window
with a diameter of 6.0 mm was attached to the frame on the
surgical side with a clip to provide visual access to the fascial side of
the opposite skin layer. Tumors were initiated by implanting a
spheroid or a tumor fragment with a diameter of 200–1200 mm
directly onto the fascial side of the intact skin layer. After chamber
implantation, the mice were kept at 32uC and 50–120% humidity.
Intravital Microscopy
Imaging was performed with an inverted fluorescence micro-
scope equipped with filters for green and red light (IX-71;
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(C9300-024; Hamamatsu Photonics, Hamamatsu, Japan), and
appropriate image acquisition software (Wasabi; Hamamatsu
Photonics). During imaging, the mice were kept in a specially
constructed holder that fixed the window chamber to the
microscope stage. Tetramethylrhodamine isothiocyanate-labeled
(TRITC)-dextran with molecular weight of 155 kDa (Sigma
Aldrich, St. Louis, MO) was used as a vascular tracer. A first-
pass imaging movie was recorded after injection of a 0.2 ml bolus
of TRITC-dextran (50 mg/ml) into the lateral tail vein. The
movie was recorded at a frame rate of 22.3 fps by use of a 62
objective lens, resulting in a time resolution of 44.8 ms, a field of
view of 5.9765.97 mm
2, and a pixel size of 7.4667.46 mm
2. For
analysis of vascular morphology, the tumor vasculature was
mapped by recording 1 to 4 single frames with a64 objective lens,
resulting in a field of view of 3.8063.80 mm
2 and a pixel size of
3.7163.71 mm
2. All recordings were stored and analyzed offline.
Analysis of Vascular Morphology
Two-dimensional projected vascular masks were established
from stored images both manually and by using an in-house made
computer program. The algorithms used for identification of
microvascular networks were implemented in MATLAB software
(The MathWorks, Natick, MA) as previously described [33]. The
following morphological parameters were calculated from masks
obtained from high-magnification images recorded with a 64
objective lens: vascular area fraction (# pixels in the vascular
mask/# tumor pixels), total vessel density (total vessel length per
tumor area), density of large vessels (length of vessels with diameter
.20 mm per tumor area), and median vessel diameter. Vessel
segment length (i.e. the distance between branching points along a
vessel) and vessel tortuosity were measured in high-magnification
transillumination images. Vessel tortuosity (T) was defined as T
(%) = (SL-L) *100/SL, where SL represents the distance between
branching points along a vessel, and L represents the distance
between the branching points along a straight line (i.e. the shortest
possible distance between the branching points). This definition is
the same as that previously used by Tozer et al [34]. Median vessel
segment length and median vessel tortuosity were calculated from
100–1250 randomly selected vessels in each tumor.
Analysis of Vascular Function
Blood supply time (BST) images were produced by assigning a
BST value to each pixel of vascular masks established from the
movies. The BST of a pixel was defined as the time difference
between the frame showing maximum fluorescence intensity in the
pixel and the frame showing maximum fluorescence intensity in
the main supplying artery. This method has previously been
described in detail [35,36]. Two R-18-GFP tumors were excluded
from BST analysis because of noise in the intensity curves. Plasma
velocities in tumor arterioles (TAs) and tumor venules (TVs) were
calculated from the time lag of the peak fluorescence intensity
along individual vessel segments [36]. Mean TA plasma velocity
and mean TV plasma velocity were calculated from 3–12 TAs and
3–12 TVs in each tumor.
IFP Measurements
IFP was measured in the center of the tumors immediately after
intravital microscopy imaging by using a Millar SPC 320 catheter
equipped with a 2F Micro-Tip transducer with diameter 0.66 mm
(Millar Instruments, Houston, TX) [37]. The catheter was inserted
into the tumor without removing the window, and was connected
to a computer via a Millar TC-510 control unit and a model 13-
66150-50 preamplifier (Gould Instruments, Cleveland, OH). Data
acquisition was carried out by using LabVIEW software (National
Instruments, Austin, TX).
Immunohistochemical Assessment of Hypoxia
Pimonidazole hydrochloride, dissolved in 0.9% sodium chlo-
ride, was administered i.p. in doses of 30 mg/kg. The tumors were
resected approximately 4 h after pimonidazole administration and
fixed in phosphate-buffered 4% paraformaldehyde. A peroxidase-
based immunohistochemical assay was used to detect tumor
hypoxia [38]. Histological preparations were incubated with
polyclonal rabbit antiserum to pimonidazole-protein adducts.
Diaminobenzidine was used as chromogen, and hematoxylin
was used for counterstaining.
RNA Isolation and cDNA Synthesis
Total RNA was isolated from cultured A-07-GFP and R-18-
GFP cells in exponential growth. The RNeasy Mini Kit (Qiagen,
Hilden, Germany) was used according to the manufacturer’s
instructions. Possible genomic DNA contaminations were removed
by on column DNAse treatment with the RNase-free DNAse Set
(Qiagen). RNA concentration and purity were measured with a
NanoDrop spectrophotometer (ND-1000; Thermo Fisher Scien-
tific Inc, Wilmington, DE). 1 mg total RNA was converted to
cDNA using the RT Profiler First Strand Kit (SABiosciences,
Frederick, MD) according to the manufacturer’s instructions.
Quantitative PCR
The 84-gene PCR array RT
2 Profiler PCR Array Human
Angiogenesis (PAHS-024A) from SABiosciences was used for
expression profiling of genes known to be involved in angiogenesis.
102 ml diluted cDNA was mixed with 1350 mlR T
2 SYBR Green
ROX qPCR Mastermix (Qiagen) and 1248 mlH 2O, and 25 mlo f
this experimental cocktail was added to each well of the 96-well
array plate. Real-time PCR was performed on an ABI 7900HT
Fast Real-Time PCR instrument (Applied Biosystems, Carlsbad,
CA). The cycling program consisted of one DNA polymerase
activation cycle (10 min at 95uC) and 40 amplification cycles (15 s
at 95uC followed by 1 min at 60uC). The threshold cycle (CT) for
each well was calculated by using the instrument’s software. Each
tumor line was run in three biological replicates. Data analysis was
performed as recommended by the manufacturer. A CT-value of
33 (15 cycles above the positive PCR control) was defined as the
detection limit of the system and, consequently, all CT-values
above 33 were set to 33 in the analysis. The array included 5
endogenous control genes (housekeeping genes). Two of these
genes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
b-actin (ACTB), showed stable expression across 5 different
melanoma lines (data not shown) and were chosen as normaliza-
tion genes. Thus, each replicate CT-value was normalized to the
mean CT of GAPDH and ACTB (DCT =C T
gene of interest -
CT
mean(GAPDH,ACTB)). The normalized expression level of each
gene was calculated from the 3 biological replicates as 2- mean
DCT. Significantly expressed genes were defined as genes with
mean CT ,33. Furthermore, genes were considered to have high
expression if 2
- mean DCT .0.001 (corresponding to a CT-value of
,26).
Statistical Analysis
Correlations between parameters were searched for by linear
regression analysis. Statistical comparisons of data were carried
out by use of the Student’s t-test when the data complied with the
conditions of normality and equal variance and otherwise by non-
parametric analysis using the Mann-Whitney rank sum test.
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tical analysis was performed with SigmaStat statistical software
(SPSS, Chicago, IL).
Results
A-07-GFP and R-18-GFP Tumors Grew as Hemispheres
Thirteen A-07-GFP and 10 R-18-GFP tumors growing in dorsal
window chambers were subjected to intravital microscopy
examination and subsequent IFP measurement. The window
chamber tumors grew as hemispheres surrounded by a plastic
window and normal skin, as illustrated in Figure 1A. All tumors
were highly vascularized, and the supplying arteries and the
draining veins were located in the surrounding normal tissue
within the chamber. Two different tumor planes parallel to the
window are indicated in Figure 1A. Plane 1 represents the plane
imaged with intravital microscopy, while plane 2 represents the
tumor center, where IFP was measured. Pimonidazole-stained
histological sections corresponding to these two planes are
presented for two different R-18-GFP tumors in Figure 1B and
1C. Both tumors showed a similar hypoxia staining pattern in the
two planes (Figure 1B-C, upper vs. lower panels). Moreover, the
hypoxia staining patterns differed substantially between the two
tumors, with peripheral staining in one tumor (Figure 1B), and
scattered staining throughout the tumor in the other (Figure 1C).
High IFP Correlated with Low Growth Rate in A-07-GFP
Tumors and with High Growth Rate in R-18-GFP Tumors
IFP in individual A-07-GFP tumors ranged from 4 to 32 mmHg
with a mean value of 19.3 mmHg, whereas IFP in individual R-
18-GFP tumors ranged from 2 to 30 mmHg with a mean value of
15.5 mmHg. There was no significant difference in IFP between
A-07-GFP and R-18-GFP tumors (Figure 2A; P.0.05). The
experiments were performed on the day the tumors had reached
their maximum size within the chamber. This resulted in a
variation in growth time that reflected the variation in growth rate
between individual tumors. The growth time varied from 9 to
16 days for A-07-GFP tumors, and from 14 to 22 days for R-18-
GFP tumors. High IFP was associated with low growth rate in A-
07-GFP tumors. Thus, a positive correlation was found between
IFP and growth time (Figure 2B; P=0.008). Conversely, high IFP
was associated with high growth rate in R-18-GFP tumors. Thus,
an inverse correlation was found between IFP and growth time in
R-18-GFP tumors (Figure 2C; P=0.04).
High IFP Correlated with Low Vascular Density in A-07-
GFP Tumors and with High Vascular Density in R-18-GFP
Tumors
Vascular networks of three A-07-GFP and three R-18-GFP
tumors varying widely in IFP are shown in Figure 3A and 3B,
respectively. Qualitative studies revealed a tendency for vascular
density to decrease with increasing IFP in A-07-GFP tumors
(Figure 3A) and to increase with increasing IFP in R-18-GFP
tumors (Figure 3B). This was studied quantitatively by using three
different parameters for vascular density: vascular area fraction,
total vessel density, and density of large vessels (vessels with
diameter .20 mm). The quantitative data were in accordance with
the qualitative observations (Figure 3C-E). Thus, in A-07-GFP
tumors, significant inverse correlations were found between IFP
and vascular area fraction (Figure 3C, left; P=0.05) and between
IFP and density of large vessels (Figure 3E, left; P=0.03). In R-18-
GFP tumors, a significant positive correlation was found between
IFP and total vessel density (Figure 3D, right; P=0.006). IFP also
tended to decrease with increasing total vessel density in A-07-
GFP tumors and to increase with increasing vascular area fraction
or density of large vessels in R-18-GFP tumors, although the
correlations were not statistically significant (Figure 3C-E, dotted
lines; P.0.05). Interestingly, small vessels contributed significantly
to the positive correlation found between IFP and vascular density
in R-18-GFP tumors (i.e. total vessel density was significantly
correlated to IFP while density of large vessels was not).
Conversely, only large vessels contributed to the inverse correla-
tion between IFP and vascular density in A-07-GFP tumors (i.e.
density of large vessels was significantly correlated to IFP while
total vessel density was not).
High IFP Correlated with High Plasma Velocity in Tumor
Arterioles Relative to Tumor Venules
To study the relationship between IFP and tumor vasculature
further, vascular function was quantified using the parameter BST.
Figure4Aand4BshowBSTimagesandBSTfrequencydistributions
of the same tumors as those illustrated in Figure 3A and 3B,
respectively.BSTincreasedwithincreasingIFPinA-07-GFPtumors
(Figure 4A)but notinR-18-GFP tumors (Figure4B).Moreover, the
intratumorvariationinBSTincreasedwithincreasingIFPinbothA-
07-GFP and R-18-GFP tumors (Figure 4A and 4B). Quantitative
analysis of the BST frequency distributions confirmed these
observations (Figure 4C). Thus, median BST was significantly
correlatedtoIFPinA-07-GFPtumors(P=0.02)butnotinR-18-GFP
tumors(P.0.05).ThisresultedinnogeneralcorrelationbetweenIFP
and median BST with all tumors pooled together (Figure 4C, left;
P.0.05). On the other hand, a significant correlation was found
between IFP and variance BST with all tumors pooled together
(Figure 4C, right; P=0.008).
High variance BST indicates that it takes a long time for the
blood to pass from the tumor arterioles to the tumor venules. This
time will depend on the total distance along tumor vessels, the
blood flow velocity in the supplying arteries, and the decrease in
blood flow velocity from the tumor arterioles to the tumor venules
as a result of blood flow resistance in the tumor capillary network.
We hypothesized that the positive correlation found between IFP
and variance BST was a result of a larger decrease in blood flow
velocity from the tumor arterioles to the tumor venules in the
tumors with high IFP than in those with low IFP. To test this
hypothesis, we measured the plasma velocity in tumor arterioles
(TAs) and tumor venules (TVs) (Figure 4D, left). As expected, the
plasma velocity decreased from the TAs to the TVs in all tumors.
However, the ratio of TA velocity to TV velocity varied widely
among individual tumors. Thus, the plasma velocity was up to 6-
fold higher in the TAs than in the TVs in some tumors. There was
a significant positive correlation between IFP and the ratio of TA
plasma velocity to TV plasma velocity (Figure 4D, right;P
=0.006). This correlation was not a consequence of differences on
the arterial side of the tumor microvasculature, as there was no
correlation between IFP and TA plasma velocity (Figure 4E, left;
P.0.05). Furthermore, IFP correlated with TV plasma velocity
(Figure 4E, middle panel; P=0.02) but not with TV diameter
(Figure 4E, right;P .0.05), suggesting that the blood flow resistance
in the tumor capillary networks rather than the blood flow
resistance in the tumor venules was associated with high IFP in A-
07-GFP and R-18-GFP tumors.
A-07-GFP Tumors with High IFP Showed High Vessel
Tortuosity
The opposite correlations found between IFP and growth rate
or vascular density in A-07-GFP and R-18-GFP tumors suggest
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e40006Figure 1. Growth and histology of window chamber tumors. A) Schematic illustration of a transversal section through a tumor growing in the
dorsal skin fold window chamber. Dark grey areas represent normal tissue, light grey areas represent tumor tissue, red areas represent vasculature,
and the light blue area represents the plastic window. Two planes parallel to the window are indicated. Plane 1 represents the plane imaged with
intravital microscopy while plane 2 represents a plane through the tumor center, where IFP was measured. B-C) Histological sections stained for the
hypoxia marker pimonidazole corresponding to the planes indicated in A) for R-18-GFP tumors showing peripheral staining (B) and scattered staining
(C). Scale bars, 1 mm.
doi:10.1371/journal.pone.0040006.g001
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resistance and, hence, elevated IFP in the two melanoma lines.
To search for possible mechanisms, vessel diameter, vessel segment
length, and vessel tortuosity were quantified. No correlations were
found between IFP and median vessel diameter or between IFP
and median vessel segment length in either tumor line (P.0.05;
data not shown). There was however a positive correlation
between IFP and median vessel tortuosity in A-07-GFP tumors
(Figure 5A; P=0.02). High vessel tortuosity also correlated with
long growth time and with low vascular area fraction in these
tumors (P=0.01 and P=0.008 respectively; data not shown).
Thus, A-07-GFP tumors with low growth rate, low vascular
density, and high IFP showed highly tortuous vessels indicating
high geometric resistance to blood flow. In contrast, there was no
correlation between IFP and median vessel tortuosity in R-18-GFP
tumors (Figure 5B; P.0.05).
The Direction of Blood Flow in R-18-GFP Tumors was
from the Center to the Periphery
To search further for possible mechanisms causing high blood
flow resistance in A-07-GFP and R-18-GFP tumors, intratumor
heterogeneity in BST and vascular morphology was investigated.
Qualitative image analysis revealed large intratumor heterogeneity
in both A-07-GFP and R-18-GFP tumors. Moreover, R-18-GFP
tumors showed a systematic radial variation in vascular density
and BST (Figure 3B and 4B) that was not observed in A-07-GFP
tumors (Figure 3A and 4A). To quantify this radial variation, all
tumors were subdivided into three concentric regions of interest
(ROIs), as illustrated in Figure 6A. Median BST and total vessel
density were then calculated in the central tumor region (ROI#1),
the middle tumor region (ROI#2), and the peripheral tumor
region (ROI#3). The radial variation in BST within each tumor
was quantified by calculating the ratio of median BST in the
middle and peripheral tumor regions relative to the central tumor
region (ratio ROI#2/ROI#1 and ratio ROI#3/ROI#1,
respectively). These ratios are shown in the upper panel of
Figure 6B. In all R-18-GFP tumors, BST increased gradually from
the center to the periphery. Thus, the BST ratios were .1, and
the BST ratio ROI#3/ROI#1 was higher than the BST ratio
ROI#2/ROI#1 in all R-18-GFP tumors. In accordance with
qualitative observations of the imaging movies, this shows that the
direction of blood flow in all R-18-GFP tumors was from the
center to the periphery. The radial variation in total vessel density
was calculated in the same way as radial variation in BST
(Figure 6B, lower panel). In most R-18-GFP tumors, vascular density
increased from the center to the periphery. Thus, total vessel
density ratio ROI#2/ROI#1 and total vessel density ratio
ROI#3/ROI#1 were .1 in most R-18-GFP tumors. In contrast
to R-18-GFP tumors, A-07-GFP tumors showed no systematic
radial blood flow pattern and no systematic radial variation in
vessel density (Figure 6B).
R-18-GFP Tumors with High IFP Showed Late Blood
Supply and High Vessel Density in the Middle and
Peripheral Tumor Regions Relative to the Tumor Center
The BST images presented in Figure 4B show that the radial
variation in BST was more pronounced in R-18-GFP tumors with
high IFP than in R-18-GFP tumors with low IFP. Accordingly, a
positive correlation was found between IFP and BST ratio
ROI#3/ROI#1 (Figure 6C, upper panel; P=0.04). Similarly, the
vascular morphology images presented in Figure 3B show that the
radial variation in vascular density was more pronounced in R-18-
GFP tumors with high IFP than in R-18-GFP tumors with low
IFP. A strong positive correlation was found between IFP and total
vessel density ratio ROI#2/ROI#1 (Figure 6C, lower panel;
P=0.002). The vessel density ratio ROI#2/ROI#1was also
calculated for small vessels (vessels with diameter ,20 mm) and
large vessels (vessels with diameter .20 mm) separately. A
significant positive correlation was found between IFP and vessel
density ratio ROI#2/ROI#1 for small vessels (Figure 6D, left;
P=0.007), whereas no significant correlation was found for large
vessels (Figure 6D, right;P .0.05).
In R-18-GFP tumors, most tumor arterioles were located in
ROI#1, most tumor capillaries in ROI#2, and most tumor
venules in ROI#3. Thus, the blood flow from ROI#1 to ROI#2
represents blood flow from the tumor arterioles to the tumor
capillary network. The correlations found in Figure 6C suggest
that the reduction in blood flow velocity and, hence, the blood
flow resistance in the tumor capillaries of ROI#2 was decisive for
IFP. A schematic illustration of the blood flow pattern and vessel
Figure 2. IFP and growth time in individual A-07-GFP and R-18-GFP tumors. A) IFP-values measured in the center of individual A-07-GFP
and R-18-GFP tumors. B–C) IFP versus growth time for A-07-GFP (B) and R-18-GFP (C) tumors. Points represent individual A-07-GFP (N) and R-18-GFP
(D) tumors. Horizontal bars represent mean values (A). Lines represent linear regression curves (B–C).
doi:10.1371/journal.pone.0040006.g002
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tumors with high IFP is presented in Figure 6E. The tumors with
low IFP show blood flowing from the central tumor arterioles to a
low number of medium-sized tumor capillaries. The tumors with
high IFP show blood flowing from the central tumor arterioles to a
high number of narrow tumor capillaries. This results in delayed
blood supply in the peripheral tumor venules indicating high blood
flow resistance in the capillary network.
A-07 and R-18 Cells Showed Highly Different Angiogenic
Profiles
To investigate possible differences between the angiogenic
profiles of A-07-GFP and R-18-GFP tumors, the expression of 84
known angiogenesis-related genes was quantified in A-07-GFP and
R-18-GFP cells using a commercial quantitative PCR array. Of
the 84 genes, 63 (75%) showed significant expression and 32 (38%)
showed high expression in one or both melanoma lines. The
normalized expression levels of the highly expressed genes are
presented in Figure 7. Fourteen genes showed similar expression
levels in the two melanoma lines (i.e. fold difference ,10;
Figure 7A), 12 genes showed more than 10-fold higher expression
in A-07-GFP than in R-18-GFP cells (Figure 7B), and 6 genes
showed more than 10-fold higher expression in R-18-GFP than in
A-07-GFP cells (Figure 7C).
Discussion
Vascular abnormalities associated with elevated IFP were
studied by using A-07-GFP and R-18-GFP human melanomas
growing in dorsal skin fold chambers as preclinical tumor models.
These two melanoma lines were chosen for several reasons. A-07
and R-18 tumors grown intradermally in mice have been shown to
retain several biological characteristics of the donor patient’s
tumors, including angiogenic potential, histopathological appear-
ance, radiation sensitivity, and metastatic pattern [31]. Further-
more, high intertumor heterogeneity in IFP has been demonstrat-
ed in xenografted tumors of both melanoma lines [12,39]. Finally,
A-07 and R-18 tumors have been shown to differ significantly in
Figure 3. IFP and vascular density. Fluorescence images showing vascular networks of A-07-GFP (A) and R-18-GFP (B) tumors representing low
(upper panel), intermediate (middle panel), and high (lower panel) IFP values. Scale bars, 1 mm. C–E) IFP versus vascular density calculated as
vascular area fraction (C), total vessel density (D), and density of large vessels (density of vessels with diameter .20 mm) (E). Points represent
individual A-07-GFP (N) and R-18-GFP (D) tumors. Lines represent linear regression curves. Solid lines, P,0.05; dotted lines, P.0.05.
doi:10.1371/journal.pone.0040006.g003
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angiogenesis, higher microvascular density, and higher perfusion
rates than R-18 tumors [40].
It has been suggested that window chamber tumors growing as
thin sheets between two windows may show higher IFP than
three-dimensional tumors as a result of restrictions in growth and
fluid flow [33,41]. The tumors in the present study grew in a
hemisphere shape in chambers with one single window, thus
allowing high resolution imaging of vascular function and
morphology in three-dimensional tumors that were accessible
for IFP measurement without window removal. In this window
chamber model, IFP was measured in the center of the tumors
while the vascular parameters were measured in a plane close to
the window. The tumor region defined as tumor center in the
intravital microscopy images was located far from the supplying
arteries and the draining veins in the normal tissue. The
vasculature in this region was therefore expected to be
representative of the vasculature in the tumor center rather than
the tumor rim. Consequently, the vascular parameters measured
close to the window were expected to be highly relevant for the
IFP measured in the tumor center. The present data support this
assumption. Thus, the hypoxia staining pattern in a plane close
to the window was representative of the hypoxia staining pattern
in a plane through the center of the tumor. Moreover, significant
correlations were found between IFP and vascular parameters in
both A-07-GFP and R-18-GFP tumors. The present data also
show that differences in biological characteristics between A-07
and R-18 tumors were retained in the window chamber model,
including growth rate and vascular density [31]. Furthermore,
the IFP values measured in the A-07-GFP and R-18-GFP tumors
in the present study were within the range of IFP values
measured previously in small intradermal A-07 and R-18 tumors
[12]. Consequently, A-07-GFP and R-18-GFP window chamber
tumors were considered well-suited models for studying the
association between IFP and vascular parameters.
Some tumors are characterized by microvessels with high
resistance to transcapillary fluid flow, and the IFP of these tumors
is expected to be lower than the microvascular hydrostatic
pressure. IFP-values lower than the microvascular hydrostatic
pressure has been demonstrated in experimental tumors [21], and
in these tumors IFP is not necessarily correlated to morphological
parameters governing the geometric resistance to blood flow. Most
tumors however, are characterized by microvessels with low
resistance to transcapillary fluid flow [42,43]. Theoretical and
experimental studies have demonstrated that in this case, IFP is
governed primarily by the microvascular hydrostatic pressure
[7,18,24,44]. Consequently, intertumor heterogeneity in IFP is
expected to reflect intertumor heterogeneity in geometric and/or
viscous resistance to blood flow in the microvascular networks of
these tumors [1].
The microvessels of xenografted A-07 and R-18 tumors are
characterized by incomplete endothelial lining, interrupted or
absent basement membrane, and high vascular permeability to
macromolecules [31,45]. A-07-GFP and R-18-GFP tumors are
thus representative of tumors showing low resistance to transcap-
illary fluid flow. Consequently, even though microvascular
hydrostatic pressure was not measured in the present study, it is
highly reasonable to expect that IFP was determined primarily by
the microvascular hydrostatic pressure and, hence, the microvas-
cular blood flow resistance in these two melanoma lines. The
present study is consistent with this assumption. Thus, high IFP
was associated with high vessel tortuosity in A-07-GFP tumors and
with high density of narrow tumor capillaries in R-18-GFP
tumors. Vascular networks characterized by high vessel tortuosity
or by low vessel diameters show high geometric resistance to blood
flow, high microvascular pressure, and low blood flow velocities
[15,16]. Accordingly, a large decrease in blood flow velocity from
Figure 4. IFP and vascular function. Blood supply time (BST) images and BST frequency distributions of A-07-GFP (A) and R-18-GFP (B) tumors
representing low (upper panel), intermediate (middle panel), and high (lower panel) IFP values. Scale bars, 1 mm; color bars, BST scale in seconds.
Vertical lines in BST frequency distributions indicate median BST. C) IFP versus median BST (left) and variance BST (right). D) Plasma velocity in tumor
arterioles (TAs; red symbols) and tumor venules (TVs; blue symbols), and IFP versus ratio of TA plasma velocity to TV plasma velocity. E) IFP versus TA
plasma velocity (left panel), TV plasma velocity (middle panel), and TV diameter (right panel). Points represent individual A-07-GFP (N) and R-18-GFP
(D) tumors. Horizontal bars represent mean values. Lines represent linear regression curves.
doi:10.1371/journal.pone.0040006.g004
Figure 5. IFP and vessel tortuosity. IFP versus median vessel tortuosity in A-07-GFP (A) and R-18-GFP (B) tumors. Points represent individual A-
07-GFP (N) and R-18-GFP (D) tumors. Lines represent linear regression curves.
doi:10.1371/journal.pone.0040006.g005
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GFP and R-18-GFP tumors with high IFP.
The vascular abnormalities that caused elevated IFP in A-07-
GFP and R-18-GFP tumors were tumor-line specific. Moreover,
the vascular architecture and blood flow patterns were distinctly
different in A-07-GFP and R-18-GFP tumors. The present study
further shows that these melanoma lines may differ substantially in
angiogenic profile. Thus, of the 32 angiogenesis-related genes
identified to have high expression in one or both melanoma lines,
38% showed more than 10-fold higher expression in A-07-GFP
than in R-18-GFP cells, while 19% showed more than 10-fold
higher expression in R-18-GFP than in A-07-GFP cells. The genes
with higher expression in A-07-GFP cells included genes encoding
for the pro-angiogenic factors interleukin-8 (IL-8) and basic
fibroblast growth factor (bFGF). We have previously shown that
the secretion rates of IL-8 and bFGF are significantly higher for A-
07 than for R-18 cells, and that treatment with blocking antibodies
against these factors significantly reduced angiogenic activity in A-
07 but not R-18 tumors [46]. Consequently, it is likely that the
tumor-line specific vascular abnormalities associated with high IFP
in the present study were results of angiogenic activity caused by
different angiogenic factors in the two melanoma lines.
The data reported here show that high IFP was associated with
low growth rate and low vascular density in A-07-GFP tumors,
Figure 6. IFP and intratumor heterogeneity in R-18-GFP tumors. A) Illustration of concentric regions of interest: ROI#1, ROI#2, and ROI#3.
Upper panel: BST-images. Lower panel: morphology images. B) Intertumor heterogeneity in BST (upper panel) and vascular density (lower panel) in
A-07-GFP and R-18-GFP tumors calculated as median BST and total vessel density in ROI#2 and in ROI#3 relative to ROI#1 (ratio ROI#2/ROI#1 and
ratio ROI#3/ROI#1). C) IFP versus BST ratio ROI#3/ROI#1 and IFP versus total vessel density ratio ROI#2/ROI#1 in R-18-GFP tumors. D) Vessel
density ratio ROI#2/ROI#1 for small vessels (diameter ,20 mm) and for large vessels (diameter .20 mm) in R-18-GFP tumors. Points represent
individual A-07-GFP (N) and R-18-GFP (D) tumors. Horizontal bars represent mean values. Lines represent linear regression curves. E) Schematic
illustration of blood flow pattern and vessel distribution in R-18-GFP tumors with low IFP and R-18-GFP tumors with high IFP. Red color indicates early
blood supply; blue color indicates late blood supply.
doi:10.1371/journal.pone.0040006.g006
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tumors. We have previously shown that tumor growth was closely
related to angiogenic activity in a study of 4 melanoma lines,
including A-07 and R-18 [31]. This relationship was confirmed in
a more recent study including a total of 9 melanoma lines [47].
Therefore, it is likely that the combination of low growth rate and
low vascular density observed in A-07-GFP tumors with high IFP
indicated low angiogenic activity, while the combination of high
growth rate and high vascular density observed in R-18-GFP
tumors with high IFP indicated high angiogenic activity. As the
vascular abnormalities associated with high IFP were distinctively
different in the two melanoma lines, it is conceivable that they
were results of high angiogenic activity in one melanoma line and
of low angiogenic activity in the other. This is consistent with the
suggestion that different angiogenic factors controlled angiogenesis
in A-07-GFP and R-18-GFP tumors. Furthermore, the present
data are consistent with previous studies in our lab. Thus, high IFP
has previously been shown to correlate with low vessel density in
A-07-GFP window chamber tumors [11]. Moreover, high IFP has
been associated with high concentration of VEGF-A in small
intradermal R-18 tumors [12]. As angiogenesis in R-18 tumors has
been shown to depend on VEGF-A [46], R-18 tumors with high
concentration of VEGF-A are expected to show higher angiogenic
activity than R-18 tumors with low concentration of VEGF-A.
InordertodevelopeffectivestrategiesforloweringtumorIFPand,
consequently, improve patient outcome, a thorough understanding
of the basic mechanisms of elevated IFP in tumors is essential. The
present study suggests that different angiogenic factors may be
responsibleforvascularabnormalitiesleadingtohighIFPindifferent
human tumorsofthesamehistological type. Strategiesto normalize
the tumor vasculature with anti-angiogenic agents should therefore
most likely be individualized based on the angiogenic profile of the
tumor. In order to individualize treatment and monitor treatment
effect, reliable and non-invasive biomarkers for IFP are highly
warranted. Different vascular parameters have been proposed as
potential biomarkers, including blood perfusion and relative tumor
blood volume measured by dynamic contrast-enhanced MRI
[39,48]. The present study suggests that these vascular parameters
may have limited potential as clinical biomarkers for IFP, as tumors
derived from two different melanoma lines demonstrated opposite
relationships betweenIFP and vascular density.
In summary, high IFP was associated with high geometric
resistance to blood flow caused by tumor-line specific vascular
abnormalities in xenografted tumors from two human melanoma
lines with different angiogenic profiles. The vascular abnormalities
responsible for high IFP were associated with high angiogenic
activity in one melanoma line, and with low angiogenic activity in
the other. These observations show that the relationship between
tumor angiogenesis and IFP is complex and may differ substan-
tially among human tumors of the same histological type.
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